Metrics
- Price
- $13.96
- Market Cap $M
- 760
- Rel Volume
- 0.86
- Vol Up 2W
- 44.40%
- Vol Trend 2W
- -5.30%
- 1D
- -0.36%
- 1W
- -2.45%
- 1M
- +46.33%
- 1M Slope
- +57.01%
- 6M Range
- 83.86%
- Score
- 84.4
- Sharp
- 2.8
Volume
Profile
Immix Biopharma develops cell therapy and oncology drug candidates for difficult-to-treat cancers, advancing clinical-stage programs and potential combination treatments.
Biotech
Pharmaceuticals